Emergent Product Development Gaithersburg Inc.
Emergent Product Development Gaithersburg Inc. received $76.8M in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 49.6% from $152.4M the year before, and $745.4M since FY2022. Its largest customer is the Department of Health and Human Services.
Contractor details
- Unique Entity ID (UEI)
- CNPVCR8DK7M8
- CAGE code
- 057Y1
- Headquarters
- Gaithersburg, MD
- Business size
- Other Than Small Business
- Parent company
- Emergent Biosolutions Inc (UEI DKEFA8JAW3X4)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $76.8M | $750.7M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325414 | Biological Product (except Diagnostic) Manufacturing | $52.8M | $328.4M |
| 541711 | Research and Development in Biotechnology | $24.0M | $303.2M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $11K | $118.6M |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | $0 | $546K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $328.4M |
| AN12 | Health R&D services; Health Care services; Applied Research | $289.0M |
| AN13 | Health R&D services; Health Care services; Experimental Development | $125.2M |
| C118 | Research and Development Facilities | $8.0M |
| Q301 | Reference Laboratory Testing | $11K |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N98026P00379 | Department of Health and Human Services HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | $11K | Apr 28, 2026 |
| 75A50123C00037 | Department of Health and Human Services MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN.… | $60.0M | Jul 31, 2023 |
Other Emergent Biosolutions Inc entities
UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.